Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150383426> ?p ?o ?g. }
- W3150383426 endingPage "675" @default.
- W3150383426 startingPage "665" @default.
- W3150383426 abstract "Objective Oesophageal squamous cell carcinoma (OSCC), like other squamous carcinomas, harbour highly recurrent cell cycle pathway alterations, especially hyperactivation of the CCND1/CDK4/6 axis, raising the potential for use of existing CDK4/6 inhibitors in these cancers. Although CDK4/6 inhibition has shown striking success when combined with endocrine therapy in oestrogen receptor positive breast cancer, CDK4/6 inhibitor palbociclib monotherapy has not revealed evidence of efficacy to date in OSCC clinical studies. Herein, we sought to elucidate the identification of key dependencies in OSCC as a foundation for the selection of targets whose blockade could be combined with CDK4/6 inhibition. Design We combined large-scale genomic dependency and pharmaceutical screening datasets with preclinical cell line models, to identified potential combination therapies in squamous cell cancer. Results We identified sensitivity to inhibitors to the ERBB family of receptor kinases, results clearly extending beyond the previously described minority of tumours with EGFR amplification/dependence, specifically finding a subset of OSCCs with dual dependence on ERBB3 and ERBB2. Subsequently. we demonstrated marked efficacy of combined pan-ERBB and CDK4/6 inhibition in vitro and in vivo. Furthermore, we demonstrated that squamous lineage transcription factor KLF5 facilitated activation of ERBBs in OSCC. Conclusion These results provide clear rationale for development of combined ERBB and CDK4/6 inhibition in these cancers and raises the potential for KLF5 expression as a candidate biomarker to guide the use of these agents. These data suggested that by combining existing Food and Drug Administration (FDA)-approved agents, we have the capacity to improve therapy for OSCC and other squamous cancer." @default.
- W3150383426 created "2021-04-13" @default.
- W3150383426 creator A5005838892 @default.
- W3150383426 creator A5023539776 @default.
- W3150383426 creator A5031819351 @default.
- W3150383426 creator A5035025572 @default.
- W3150383426 creator A5039205880 @default.
- W3150383426 creator A5048120045 @default.
- W3150383426 creator A5052023689 @default.
- W3150383426 creator A5054498997 @default.
- W3150383426 creator A5056373767 @default.
- W3150383426 creator A5059400884 @default.
- W3150383426 creator A5059774228 @default.
- W3150383426 creator A5061895055 @default.
- W3150383426 creator A5062969947 @default.
- W3150383426 creator A5064698919 @default.
- W3150383426 creator A5066070097 @default.
- W3150383426 creator A5079706186 @default.
- W3150383426 creator A5085232323 @default.
- W3150383426 creator A5087590041 @default.
- W3150383426 date "2021-03-31" @default.
- W3150383426 modified "2023-10-17" @default.
- W3150383426 title "Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma" @default.
- W3150383426 cites W1696775091 @default.
- W3150383426 cites W1967619397 @default.
- W3150383426 cites W1971142107 @default.
- W3150383426 cites W1984047229 @default.
- W3150383426 cites W2049610624 @default.
- W3150383426 cites W2054606083 @default.
- W3150383426 cites W2096387850 @default.
- W3150383426 cites W2096979580 @default.
- W3150383426 cites W2113814947 @default.
- W3150383426 cites W2125065379 @default.
- W3150383426 cites W2136752280 @default.
- W3150383426 cites W2144790402 @default.
- W3150383426 cites W2151730005 @default.
- W3150383426 cites W2155384808 @default.
- W3150383426 cites W2166559675 @default.
- W3150383426 cites W2260536780 @default.
- W3150383426 cites W2290950904 @default.
- W3150383426 cites W2299045691 @default.
- W3150383426 cites W2339001874 @default.
- W3150383426 cites W2346530374 @default.
- W3150383426 cites W2397565476 @default.
- W3150383426 cites W2552099557 @default.
- W3150383426 cites W2569843435 @default.
- W3150383426 cites W2570401594 @default.
- W3150383426 cites W2587916991 @default.
- W3150383426 cites W2601052641 @default.
- W3150383426 cites W2618723848 @default.
- W3150383426 cites W2724177236 @default.
- W3150383426 cites W2735625431 @default.
- W3150383426 cites W2741508285 @default.
- W3150383426 cites W2752210999 @default.
- W3150383426 cites W2769988386 @default.
- W3150383426 cites W2791410762 @default.
- W3150383426 cites W2795903481 @default.
- W3150383426 cites W2799372852 @default.
- W3150383426 cites W2807927321 @default.
- W3150383426 cites W2889051002 @default.
- W3150383426 cites W2889646458 @default.
- W3150383426 cites W2906166963 @default.
- W3150383426 cites W2923545710 @default.
- W3150383426 cites W2947984984 @default.
- W3150383426 cites W2952121859 @default.
- W3150383426 cites W2957919816 @default.
- W3150383426 cites W2961997810 @default.
- W3150383426 cites W2963353895 @default.
- W3150383426 cites W2965636231 @default.
- W3150383426 cites W2967464862 @default.
- W3150383426 cites W2976652879 @default.
- W3150383426 cites W2988009907 @default.
- W3150383426 cites W3000557314 @default.
- W3150383426 cites W3016524585 @default.
- W3150383426 cites W3037864910 @default.
- W3150383426 cites W3044880304 @default.
- W3150383426 cites W3045659462 @default.
- W3150383426 doi "https://doi.org/10.1136/gutjnl-2020-323276" @default.
- W3150383426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33789967" @default.
- W3150383426 hasPublicationYear "2021" @default.
- W3150383426 type Work @default.
- W3150383426 sameAs 3150383426 @default.
- W3150383426 citedByCount "14" @default.
- W3150383426 countsByYear W31503834262022 @default.
- W3150383426 countsByYear W31503834262023 @default.
- W3150383426 crossrefType "journal-article" @default.
- W3150383426 hasAuthorship W3150383426A5005838892 @default.
- W3150383426 hasAuthorship W3150383426A5023539776 @default.
- W3150383426 hasAuthorship W3150383426A5031819351 @default.
- W3150383426 hasAuthorship W3150383426A5035025572 @default.
- W3150383426 hasAuthorship W3150383426A5039205880 @default.
- W3150383426 hasAuthorship W3150383426A5048120045 @default.
- W3150383426 hasAuthorship W3150383426A5052023689 @default.
- W3150383426 hasAuthorship W3150383426A5054498997 @default.
- W3150383426 hasAuthorship W3150383426A5056373767 @default.
- W3150383426 hasAuthorship W3150383426A5059400884 @default.
- W3150383426 hasAuthorship W3150383426A5059774228 @default.
- W3150383426 hasAuthorship W3150383426A5061895055 @default.